HUT34887A - Process for producing composition containing purified detoxicated endotoxin - Google Patents
Process for producing composition containing purified detoxicated endotoxinInfo
- Publication number
- HUT34887A HUT34887A HU843169A HU316984A HUT34887A HU T34887 A HUT34887 A HU T34887A HU 843169 A HU843169 A HU 843169A HU 316984 A HU316984 A HU 316984A HU T34887 A HUT34887 A HU T34887A
- Authority
- HU
- Hungary
- Prior art keywords
- detoxicated
- endotoxin
- composition containing
- containing purified
- producing composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55544—Bacterial toxins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
A composition which is capable of producing an effective adjuvant response or stimulating the immune response of a warm blooded animal which comprises an effective amount of a refined detoxified endotoxin material, in combination with a pharmaceutically acceptable carrier.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52696783A | 1983-08-26 | 1983-08-26 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUT34887A true HUT34887A (en) | 1985-05-28 |
HU191713B HU191713B (en) | 1987-03-30 |
Family
ID=24099553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU843169A HU191713B (en) | 1983-08-26 | 1984-08-23 | Process for producing composition containing purified detoxicated endotoxin |
Country Status (22)
Country | Link |
---|---|
JP (1) | JPS6072825A (en) |
KR (1) | KR880002223B1 (en) |
AT (1) | AT389228B (en) |
AU (1) | AU554039B2 (en) |
BE (1) | BE900377A (en) |
CA (1) | CA1225592A (en) |
CH (1) | CH660125A5 (en) |
DE (2) | DE3448164C2 (en) |
DK (1) | DK389384A (en) |
ES (1) | ES8606883A1 (en) |
FI (1) | FI843204A (en) |
FR (1) | FR2550945B1 (en) |
GB (1) | GB2147806B (en) |
HU (1) | HU191713B (en) |
IL (1) | IL72675A (en) |
IN (1) | IN157910B (en) |
IT (1) | IT1177974B (en) |
NL (1) | NL192326C (en) |
NO (1) | NO843243L (en) |
NZ (1) | NZ209233A (en) |
SE (1) | SE8404090L (en) |
ZA (1) | ZA846309B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4629722A (en) * | 1984-07-12 | 1986-12-16 | Ribi Immunochem Research, Inc. | Method of inhibiting the onset of acute radiation syndrome |
US4806352A (en) * | 1986-04-15 | 1989-02-21 | Ribi Immunochem Research Inc. | Immunological lipid emulsion adjuvant |
US4803070A (en) * | 1986-04-15 | 1989-02-07 | Ribi Immunochem Research Inc. | Immunological emulsion adjuvants for polysaccharide vaccines |
DE10115310A1 (en) * | 2001-03-28 | 2002-10-10 | Nodar A Daniela | Bacteriophage preparation |
KR100868443B1 (en) * | 2002-05-27 | 2008-11-11 | 주식회사 포스코 | An apparatus for bending a strip packing sheet |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2160326B1 (en) * | 1971-11-19 | 1975-02-07 | Anvar | |
BE793260A (en) * | 1971-12-24 | 1973-06-22 | Pasteur Institut | IMMUNOSTIMULANT AGENT, MEDICINES CONTAINING IT AND METHOD FOR MANUFACTURING SUCH IMMUNOSTIMULANT AGENT |
DE2527636A1 (en) * | 1974-06-20 | 1976-01-08 | Anvar | METHOD FOR PRODUCING MYCOBACTERIAL FRACTIONS |
FR2393065A1 (en) * | 1977-05-31 | 1978-12-29 | Merieux Inst | PROCESS FOR SEPARATION OF LIPIDS FROM BACTERIAL ENDOTOXINS AND IN PARTICULAR FROM BORDETELLA PERTUSSIS ENDOTOXIN |
US4436727A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4436728A (en) * | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
US4435386A (en) * | 1982-05-26 | 1984-03-06 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
-
1984
- 1984-08-10 CA CA000460820A patent/CA1225592A/en not_active Expired
- 1984-08-13 DK DK389384A patent/DK389384A/en not_active Application Discontinuation
- 1984-08-14 GB GB08420612A patent/GB2147806B/en not_active Expired
- 1984-08-14 IN IN567/CAL/84A patent/IN157910B/en unknown
- 1984-08-14 ES ES535124A patent/ES8606883A1/en not_active Expired
- 1984-08-14 IL IL72675A patent/IL72675A/en not_active IP Right Cessation
- 1984-08-14 SE SE8404090A patent/SE8404090L/en not_active Application Discontinuation
- 1984-08-14 NO NO843243A patent/NO843243L/en unknown
- 1984-08-14 FI FI843204A patent/FI843204A/en not_active Application Discontinuation
- 1984-08-14 ZA ZA846309A patent/ZA846309B/en unknown
- 1984-08-15 NZ NZ209233A patent/NZ209233A/en unknown
- 1984-08-16 NL NL8402515A patent/NL192326C/en not_active IP Right Cessation
- 1984-08-17 BE BE0/213506A patent/BE900377A/en not_active IP Right Cessation
- 1984-08-21 CH CH4001/84A patent/CH660125A5/en not_active IP Right Cessation
- 1984-08-21 AU AU32215/84A patent/AU554039B2/en not_active Expired
- 1984-08-23 HU HU843169A patent/HU191713B/en unknown
- 1984-08-23 DE DE3448164A patent/DE3448164C2/de not_active Expired
- 1984-08-23 DE DE19843431058 patent/DE3431058A1/en active Granted
- 1984-08-23 FR FR8413133A patent/FR2550945B1/en not_active Expired
- 1984-08-24 IT IT48757/84A patent/IT1177974B/en active
- 1984-08-25 JP JP59175877A patent/JPS6072825A/en active Granted
- 1984-08-25 KR KR1019840005189A patent/KR880002223B1/en not_active IP Right Cessation
- 1984-08-27 AT AT0273384A patent/AT389228B/en not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2210557B (en) | Vaccine containing tumor antigens and refined detoxified endotoxin as an adjuvant. | |
IL73034A (en) | Pharmaceutical composition containing refined detoxified endotoxin and a pyridine-soluble extract of a microorganism | |
AU566011B2 (en) | Leather treatment composition | |
HUT35287A (en) | Process for preparing immune interferon | |
EP0294028A3 (en) | Fluoxetine useful for the treatment of diabetes | |
GB2211845B (en) | Process for dechlorinating 4,5-dichlorofluoro-dioxolanes to obtain fluorodioxoles | |
EP0253313A3 (en) | Process for heat treating chemically unmodified gamma-globulin | |
HUT34887A (en) | Process for producing composition containing purified detoxicated endotoxin | |
GR871606B (en) | 7- deazaguanines as immun omodulators | |
HUT36783A (en) | Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane | |
EP0266633A3 (en) | Process for the preparation of organopolysiloxanes containing sih-bonds | |
HUT43107A (en) | Process for producing vaccine against melanome | |
EP0254068A3 (en) | Novel therapeutic agent for gastritis | |
PL238609A2 (en) | Process for preparing novel pyrimidine/1,3/oxazin-2,4-diones | |
ZA838815B (en) | Process for the preparation of n,n'-diformylhydrazine | |
CA49742S (en) | Treatment chair | |
CA49712S (en) | Table ornament | |
CA50525S (en) | Table ornament | |
ZA827535B (en) | A composition for progestational adjuvant therapy | |
SU1486325A1 (en) | Method of preparing parts to the treatment | |
BG33354A1 (en) | Method for obtaining of 3- substttuated- 1, 2, 4- oxadiazol |